Linagliptin is associated to increased treatment adherence and satisfaction in elderly outpatients with diabetes and advanced chronic kidney disease

Por Franco Gregorio, Eleonora Guerrini, Daniele Gregorio, Giorgio Montecchiani
Publicado em 2016-11-01